e-learning
resources
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Outcomes for COPD pharmacological trials: from lung function to Biomarkers
M. Cazzola, W. MacNee, F.J. Martinez, et al.
Source:
Guideline 2008
Number:
2008
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Cazzola, W. MacNee, F.J. Martinez, et al.. Outcomes for COPD pharmacological trials: from lung function to Biomarkers. Guideline 2008
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Source: Eur Respir J 2008; 31: 416-469
Year: 2008
Individual dynamic of inflammatory markers as indicators of COPD treatment effectiveness
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE study
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Lung function decline in COPD trials
Source: Eur Respir J 2009; 33: 708-709
Year: 2009
Pharmacological treatment of COPD in the on-sint cohort
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Functional Respiratory Imaging as a sensitive biomarker to assess therapeutic interventions in lung diseases
Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles
Year: 2015
Evaluating cardiac safety of tiotropium in patients with COPD: Combined analysis of Holter-ECG data from four trials
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014
Lung function with aclidinium/formoterol fixed-dose combination: Pooled analysis of two phase III studies in COPD
Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Year: 2015
Roflumilast for stable COPD: Meta-analysis of randomized controlled trials
Source: International Congress 2014 – Clinical presentations
Year: 2014
Bronchodilator response of advanced lung function parameters depending on COPD severity
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Laboratory and clinical parameters in predicting risk of future exacerbations in both non-smoking and smoking COPD patients
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Endpoints in IPF and lung cancer trials: controversies and perspectives
Source: Research Seminar 2015
Year: 2015
Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Biomarkers in COPD exacerbation, the role of adiponectin
Source: International Congress 2014 – Predictors
Year: 2014
Body-plethysmographic measurements of bronchodilator response in stable COPD
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014
Assessment of lung function in patients with COPD using the Inspired Sinewave Technique
Source: International Congress 2017 – Lung function testing in different patient categories
Year: 2017
Lung function and treatment patterns of symptomatic patients with moderate COPD in the CRYSTAL study
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Pulmonary hypertension and COPD: Clinical assessment and biomarkers
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
The effects of bronchodilators on regional lung sound distribution in patients with COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Relation of plasma osteopontin levels with the clinical course in patients with COPD
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept